Carolyn Rebeiro from Mining.com.au sits down with ABx Group Limited (ASX:ABX) Managing Director and CEO Dr Mark Cooksey and Corporate Connect Senior Equities Analyst Richard Close for an in-depth look at the company and its value proposition.
Copyright 2023 – Finance News Network
Source: Finance News Network
05 Feb 2024 - Chariot Corporation (ASX:CC9) Managing Director Shanthar Pathmanathan and Geological Consultant Dr Edward Max Baker discuss the significance of the company's latest drill results.
Read More27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
Read More29 Mar 2021 - Telix Pharmaceuticals Limited (ASX:TLX) Chief Business Officer Dr David Cade talks about the company's clinical programs, including approvals, partnerships and significant value events anticipated in 2021.
Read More27 Aug 2024 - Lithium Universe Limited (ASX:LU7) CEO Alex Hanly provides an update on the company, discussing collaboration with the W8banaki, listing on the Frankfurt stock exchange and the OTC Markets and outlook.
Read More06 Sep 2023 - GBM Resources Limited (ASX:GBZ) Managing Director Peter Rohner provides an update on the company's projects, discussing the JV with Newcrest Mining (ASX:NCM) and recent divestments.
Read More29 Sep 2023 - Shanthar Pathmanathan, CEO and founder of Chariot Corporation (ASX:CC9) discusses US lithium mining opportunities and expansion plans.
Read More06 May 2020 - Acorn Capital Investment Fund Ltd. (ASX: ACQ) Head of Research and Portfolio Manager for the Consumer Discretionary, Consumer Staples and Information Technology sectors, Robert Bruce talks about the listed investment company, the fund’s composition and outlook for the next 6 months and longer term.
Read More31 Mar 2021 - Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) CEO and Managing Director James Graham talks about progress with the company's lead anti-infective candidate Recce 327, its expanding portfolio of synthetic anti-infectives targeting viral pathogens and a broad range of bacteria, clinical trial results and priorities for 2021.
Read More22 Aug 2022 - archTIS Limited (ASX:AR9) CEO and Managing Director Daniel Lai discusses AR9's client base and growth plans, international markets, and collaborations with Microsoft and KPMG.
Read More18 Oct 2019 - Calima Energy Limited (ASX:CE1) Managing Director, Alan Stein, talks about the company's strategy, recent capital raising, and results from the drill program at its Montney project.
Read More
